These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4691239)

  • 21. [Preparation of factor IX concentrate with the use of DEAE-cellulose and its therapeutic results].
    Uszyński L; Poszwiński P
    Acta Haematol Pol; 1971; 2(2):109-14. PubMed ID: 5170671
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of hemophiliacs with inhibitors].
    Fujimaki M
    Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential interaction of clotting factors II, VII, IX and X with sephadex and dextran blue.
    Swart AC; Kop-Klaassen BH; Hemker HC
    Haemostasis; 1972-1973; 1(5):237-52. PubMed ID: 4670119
    [No Abstract]   [Full Text] [Related]  

  • 24. [Isolation of factor IX concentrate from cryosupernatant of donor's plasma].
    Fetisova LV; Viazova EP; Khametova RN; Shuvalova AL; Azhigirova MA; Lazarev VA; Zeĭnalov AM
    Gematol Transfuziol; 1991 Jun; 36(6):34-6. PubMed ID: 1769497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical experience with the PPSB fraction in surgery].
    Frick U
    Zentralbl Chir; 1972 Feb; 97(5):150-3. PubMed ID: 5020589
    [No Abstract]   [Full Text] [Related]  

  • 26. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
    Schimpf K; Schwarz P; Kunschak M
    Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment with prothrombin complex concentrate of postoperative bleeding in a haemophiliac with a factor VIII inhibitor.
    Lowe GD; Harvie A; Forbes CD; Prentice CR
    Br Med J; 1976 Nov; 2(6044):1110-1. PubMed ID: 990791
    [No Abstract]   [Full Text] [Related]  

  • 28. Removal of hepatitis B virus from a concentrate of coagulation factors II, VII, IX and X by hydrophobic interaction chromatography.
    Einarsson M; Kaplan L; Nordenfelt E; Miller E
    J Virol Methods; 1981 Nov; 3(4):213-28. PubMed ID: 7328163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.
    Mannucci PM; Bauer KA; Gringeri A; Barzegar S; Bottasso B; Simoni L; Rosenberg RD
    Blood; 1990 Dec; 76(12):2540-5. PubMed ID: 2265248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. THROMBOPLASTIN FORMATION.
    POOL JG
    Annu Rev Med; 1964; 15():215-32. PubMed ID: 14133846
    [No Abstract]   [Full Text] [Related]  

  • 31. Preparation and properties of a therapeutic factor IX concentrate.
    Suomela H; Myllylä G; Raaska E
    Vox Sang; 1977 Jul; 33(1):37-50. PubMed ID: 883244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Concentrated antihemophilic globulin in the treatment of hemorrhagic syndromes].
    Baklaja F; Cvetković V; Stajić M; Krivokapić L
    Bilt Hematol Transfuz; 1976; 4(3):61-6. PubMed ID: 1008799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Christmas disease and Stuart-Prower deficiency with a prothrombin-complex concentrate (factors II, VII, IX, X).
    Tullis JL; Melin M
    Bibl Haematol; 1968; 29():1134-9. PubMed ID: 5700309
    [No Abstract]   [Full Text] [Related]  

  • 34. Transfusion support for haemophiliacs.
    Allain JP
    Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thrombogenicity of prothrombin complex concentrates].
    Dornheim G; Klöcking HP; Wulkow R; Storch H; Töpfer G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):571-9. PubMed ID: 1714862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved procedures for the purification of selected vitamin K-dependent proteins.
    Novoa E; Seegers WH; Hassouna HI
    Prep Biochem; 1976; 6(5):307-38. PubMed ID: 787972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prothrombin complex concentrates: preparation, properties, and clinical uses.
    White GC; Lundblad RL; Kingdon HS
    Curr Top Hematol; 1979; 2():203-44. PubMed ID: 318075
    [No Abstract]   [Full Text] [Related]  

  • 38. Clotting factor concentrates.
    Entwistle CC
    Int Anesthesiol Clin; 1985; 23(2):49-59. PubMed ID: 3924836
    [No Abstract]   [Full Text] [Related]  

  • 39. Prothrombal: a new concentrate of human prothrombin complex for clinical use.
    Bruning PF; Loeliger EA
    Br J Haematol; 1971 Oct; 21(4):377-98. PubMed ID: 5001176
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
    O'Leary DS; Ruymann FB; Conrad ME
    J Lab Clin Med; 1971 Jan; 77(1):23-32. PubMed ID: 5540427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.